Original Research Article

Fast Cognitive Decline at the Time of Dementia Diagnosis: A Major Prognostic Factor for Survival in the Community
Laure Carcaillon^{a, b}, Karine Pérès^{a, b}, Jean-Jacques Péré^d, Catherine Helmer^{a, b}, Jean-Marc Orgogozo^a-c, Jean-François Dartigues<sup>a-c

a</sup>Inserm, Unit 593,
^bUniversity Victor Segalen and
^cUniversity Hospital Center, Bordeaux, and
^dNovartis Pharma SAS, Rueil-Malmaison, France

Address of Corresponding Author

Dement Geriatr Cogn Disord 2007;23:439-445 (DOI: 10.1159/000102017)

  Key Words

• Fast cognitive decline
• Mortality rate
• Alzheimer's disease

  Abstract

Background/Aims: Current findings suggest the existence of a category of fast cognitive decliners with a poorer prognosis but better treatment response. Our study aimed at confirming the concept of fast decliners at the time of Alzheimer's disease (AD) diagnosis which best predicts mortality, in an unselected sample. Methods: 245 incident cases of AD were selected from the French longitudinal cohort PAQUID. We investigated a different threshold of cognitive decline [measured by the annual loss of points in the Mini Mental State Examination (MMSE) score] to define when a subject could be considered as a fast decliner. We used Cox proportional hazards models to study the relation between cognitive decline and mortality. Results:The significant threshold of decline associated with a higher mortality rate was a loss of 3 points per year in the MMSE score. Among the 245 AD cases, 83 (33.9%) subjects were considered as fast decliners. Of them, 78.3% died during the follow-up compared with 63.0% of the slow decliners (RR = 1.7, 95% CI 1.2-2.5). Conclusion:These results constitute an empirical validation of the concept of fast decliners in community-based AD patients and justify the cutoff of 3 points for the definition of this condition.

Copyright © 2007 S. Karger AG, Basel

  References

1.

Farlow MR, Hake A, Messina J, Hartman R, Veach J, Anand R: Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression. Arch Neurol 2001;58:417-422.

2.

Schupf N, Tang MX, Albert SM, Costa R, Andrews H, Lee JH, Mayeux R: Decline in cognitive and functional skills increases mortality risk in nondemented elderly. Neurology 2005;65:1218-1226.

3.

Schupf N, Costa R, Tang MX, Andrews H, Tycko B, Lee JH, Mayeux R: Preservation of cognitive and functional ability as markers of longevity. Neurobiol Aging 2004;25:1231-1240.

4.

Bassuk SS, Wypij D, Berkman LF: Cognitive impairment and mortality in the community-dwelling elderly. Am J Epidemiol 2000;151:676-688.

5.

Bruce ML, Hoff RA, Jacobs SC, Leaf PJ: The effects of cognitive impairment on 9-year mortality in a community sample. J Gerontol B Psychol Sci Soc Sci 1995;50:P289-P296.

6.

Farlow MR, Small GW, Quarg P, Krause A: Efficacy of rivastigmine in Alzheimer's disease patients with rapid disease progression: results of a meta-analysis. Dement Geriatr Cogn Disord 2005;20:192-197.

7.

O'Hara R, Thompson JM, Kraemer HC, Fenn C, Taylor JL, Ross L, Yesavage JA, Bailey AM, Tinklenberg JR: Which Alzheimer patients are at risk for rapid cognitive decline? J Geriatr Psychiatry Neurol 2002;15:233-238.

8.

Wilson RS, Li Y, Aggarwal NT, McCann JJ, Gilley DW, Bienias JL, Barnes LL, Evans DA: Cognitive decline and survival in Alzheimer's disease. Int J Geriatr Psychiatry 2006;21:356-362.

9.

Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, Kukull WA: Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 2004;140:501-509.

10.

Dartigues JF, Gagnon M, Michel P, Letenneur L, Commenges D, Barberger-Gateau P, Auriacombe S, Rigal B, Bedry R, Alperovitch A, et al: The Paquid research program on the epidemiology of dementia. Methods and initial results. Rev Neurol (Paris) 1991;147:225-230.

11.

Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.

12.

Benton A: Manuel pour l'application du test de rétention visuelle. Applications cliniques et expérimentales, ed 2. Paris, Centre de Psychologie Appliquée, 1965.

13.

Zazzo R: Test des deux barrages. Actualités pédagogiques et psychologiques. Neuchâtel, Delachaux et Niestle, 1974, vol 7.

14.

Isaacs B, Kennie AT: The Set test as an aid to the detection of dementia in old people. Br J Psychiatry 1973;123:467-470.

15.

Wechsler D: WAIS-R Manual. New York, Psychological Corporation, 1981.

16.

Pichot P: DSM-III: the 3rd edition of the Diagnostic and Statistical Manual of Mental Disorders from the American Psychiatric Association. Rev Neurol (Paris) 1986;142:489-499.

17.

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.

18.

Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, Russell RW, Symon L: Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637.

19.

Cox D: Regression models in life tables (with discussion). J R Stat Soc 1972;34:187-220.

20.

Letenneur L, Gilleron V, Commenges D, Helmer C, Orgogozo M, Dartigues JF: Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry 1999;66:177-183.

21.

Lechevallier-Michel N, Molimard M, Dartigues JF, Fabrigoule C, Fourrier-Reglat A: Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol 2005;59:143-151.

22.

Doody RS, Massman P, Dunn JK: A method for estimating progression rates in Alzheimer disease. Arch Neurol 2001;58:449-454.

23.

Stern Y, Tang MX, Denaro J, Mayeux R: Increased risk of mortality in Alzheimer's disease patients with more advanced educational and occupational attainment. Ann Neurol 1995;37:590-595.

24.

Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R: Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994;271:1004-1010.

  Author Contacts

Jean-François Dartigues
Inserm U593 - PAQUID - Case 11
146, rue Léo-Saignat, FR-33076 Bordeaux Cedex (France)
Tel. +33 5 57 57 15 02, Fax +33 5 57 57 14 86
E-Mail jean-francois.dartigues@isped.u-bordeaux2.fr

  Article Information

Accepted: February 26, 2007
Published online: April 26, 2007
Number of Print Pages : 7
Number of Figures : 2, Number of Tables : 3, Number of References : 24

  Publication Details

Dementia and Geriatric Cognitive Disorders

Vol. 23, No. 6, Year 2007 (Cover Date: May 2007)

Journal Editor: Chan-Palay, V. (New York, N.Y.)
ISSN: 1420-8008 (print), 1421-9824 (Online)

For additional information: http://www.karger.com/DEM

  Drug Dosage / Copyright

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.